Literature DB >> 6782822

Refractive change in alloxan diabetic rabbits. Control by flavonoids I.

S D Varma, H K El-Aguizy, R D Richards.   

Abstract

The rabbit eye is hyperopic by approximately 4D. The induction of diabetes leads to a further enhancement in the degree of hyperopia. This enhancement is attenuated substantially by flavonoids as inhibitors of aldose reduction. The development of refractive changes in diabetic lens involves aldose reductase catalyzed polyol synthesis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6782822     DOI: 10.1111/j.1755-3768.1980.tb06688.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  6 in total

1.  Long-term influence of insulin dependent diabetes mellitus on refraction and its components: a population based twin study.

Authors:  N Løgstrup; A K Sjølie; K O Kyvik; A Green
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

2.  Myopia in young patients with type 1 diabetes mellitus.

Authors:  Swati Handa; Audrey Chia; Hla Myint Htoon; Pin Min Lam; Fabian Yap; Yvonne Ling
Journal:  Singapore Med J       Date:  2015-08       Impact factor: 1.858

3.  Ocular effects of acute hyperglycaemia.

Authors:  D Poinoosawmy; A F Winder
Journal:  Br J Ophthalmol       Date:  1984-08       Impact factor: 4.638

4.  Refractive change in hyperglycaemia: hyperopia, not myopia.

Authors:  P R Eva; P T Pascoe; D G Vaughan
Journal:  Br J Ophthalmol       Date:  1982-08       Impact factor: 4.638

5.  Transient hyperopia with lens swelling at initial therapy in diabetes.

Authors:  Y Saito; G Ohmi; S Kinoshita; Y Nakamura; K Ogawa; S Harino; M Okada
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

6.  Refractive properties of the healthy human eye during acute hyperglycemia.

Authors:  Nanouk G M Wiemer; Elisabeth M W Eekhoff; Suat Simsek; Robert J Heine; Peter J Ringens; Bettine C P Polak; Michiel Dubbelman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-04       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.